Come hear from seasonal Biotech ecosystem investors and entrepreneurs. Hear about key trends in biotech investing. Growth of the SoCal community. Recent fundings and exits. Pros and cons of investing in early and later stage biotech and medtech. Role of IP in Biotech. Learn the common dos/don'ts as early stage investors in biopharma.
Answers to common questions such as: What is the archetype of a successful investment and team in biopharma? When should a team be replaced/how should early-stage investors like angels think through this? How did COVID impact Biotech investing (e.g. mRNA treatments, anti-virals)? Impact of Biogen's new Alzheimer's drug?
Matt Thompson - TCA LA Moderator - https://tech-coast-angels.proseeder.com/linkedin.com/in/melishthompson
Ryan Witt - TCA LA Moderator - https://www.linkedin.com/in/ryanjwitt/
Emmett Cunningham, Senior Managing Director, Blackstone Life Sciences; Clarus Ventures
Ahmed Enany, SoCal Bio, President and CEO
Steph Hsieh, BioCom, Executive Director; Meditope, CEO
Josh's linkedin https://www.linkedin.com/in/josh-barer Josh Barer Hibiscus Capital Management Managing Director